Azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: A rare entity

In the light of this case, azygos and hemiazygos veins should be evaluated carefully in thorax CT scans. This rare case is also important in terms of the occurrence of AVT in a patient receiving rivaroxaban therapy. The outcomes and recurrence rates of these patients should also be reported for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Degirmenci, Guliz, Satici, Celal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140758/
https://www.ncbi.nlm.nih.gov/pubmed/37122819
http://dx.doi.org/10.1002/rcr2.1154
_version_ 1785033232710893568
author Degirmenci, Guliz
Satici, Celal
author_facet Degirmenci, Guliz
Satici, Celal
author_sort Degirmenci, Guliz
collection PubMed
description In the light of this case, azygos and hemiazygos veins should be evaluated carefully in thorax CT scans. This rare case is also important in terms of the occurrence of AVT in a patient receiving rivaroxaban therapy. The outcomes and recurrence rates of these patients should also be reported for the decision of anticoagulant treatment.
format Online
Article
Text
id pubmed-10140758
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-101407582023-04-29 Azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: A rare entity Degirmenci, Guliz Satici, Celal Respirol Case Rep Clinical Images In the light of this case, azygos and hemiazygos veins should be evaluated carefully in thorax CT scans. This rare case is also important in terms of the occurrence of AVT in a patient receiving rivaroxaban therapy. The outcomes and recurrence rates of these patients should also be reported for the decision of anticoagulant treatment. John Wiley & Sons, Ltd 2023-04-28 /pmc/articles/PMC10140758/ /pubmed/37122819 http://dx.doi.org/10.1002/rcr2.1154 Text en © 2023 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Images
Degirmenci, Guliz
Satici, Celal
Azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: A rare entity
title Azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: A rare entity
title_full Azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: A rare entity
title_fullStr Azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: A rare entity
title_full_unstemmed Azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: A rare entity
title_short Azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: A rare entity
title_sort azygos vein thrombosis despite rivaroxaban therapy in a patient with breast cancer: a rare entity
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140758/
https://www.ncbi.nlm.nih.gov/pubmed/37122819
http://dx.doi.org/10.1002/rcr2.1154
work_keys_str_mv AT degirmenciguliz azygosveinthrombosisdespiterivaroxabantherapyinapatientwithbreastcancerarareentity
AT saticicelal azygosveinthrombosisdespiterivaroxabantherapyinapatientwithbreastcancerarareentity

Ejemplares similares